SV2009003192A - Procedimiento de preparacion de halogenuros de n-alquil-naltrexona - Google Patents

Procedimiento de preparacion de halogenuros de n-alquil-naltrexona

Info

Publication number
SV2009003192A
SV2009003192A SV2009003192A SV2009003192A SV2009003192A SV 2009003192 A SV2009003192 A SV 2009003192A SV 2009003192 A SV2009003192 A SV 2009003192A SV 2009003192 A SV2009003192 A SV 2009003192A SV 2009003192 A SV2009003192 A SV 2009003192A
Authority
SV
El Salvador
Prior art keywords
carbonate
methyl
preparation procedure
naltrexone
naltrexona
Prior art date
Application number
SV2009003192A
Other languages
English (en)
Inventor
Alain Dlubala
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of SV2009003192A publication Critical patent/SV2009003192A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCIÓN SE REFIERE A UN NUEVO PROCEDIMIENTO DE PREPARACIÓN DEL BROMURO DE N-METIL-NALTREXONA, QUE COMPRENDE AL MENOS LAS ETAPAS QUE CONSISTEN EN: (I) HACER REACCIONAR EL METILSULFATO DE N-METIL-NALTREXONA EN SOLUCIÓN ACUOSA CON UN AGENTE ALCALINO ELEGIDO DEL GRUPO CONSTITUIDO POR CARBONATO DE SODIO, CARBONATO DE POTASIO, CARBONATO DE CALCIO, CARBONATO DE MAGNESIO, CARBONATO DE CESIO, CARBONATO DE ESTRONCIO Y LAS MEZCLAS DE ESTOS, PARA UN PH DEL MEDIO DE REACCIÓN ACUOSO COMPRENDIDO ENTRE 7 Y 10, Y DESPUÉS (II) HACER REACCIONAR EL PRODUCTO ASÍ OBTENIDO CON EL ACIDO BROMHÍDRICO QUE SE AÑADE, PARA UN PH DEL MEDIO DE REACCIÓN ACUOSO COMPRENDIDO ENTRE 0,5 Y 5 Y OBTENER ASI EL BROMURO DE N-METIL-NALTREXONA
SV2009003192A 2006-09-21 2009-03-19 Procedimiento de preparacion de halogenuros de n-alquil-naltrexona SV2009003192A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0608286A FR2906252B1 (fr) 2006-09-21 2006-09-21 Procede de preparation d'halogenures de n-aklyl naltrexone

Publications (1)

Publication Number Publication Date
SV2009003192A true SV2009003192A (es) 2009-10-27

Family

ID=38016779

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2009003192A SV2009003192A (es) 2006-09-21 2009-03-19 Procedimiento de preparacion de halogenuros de n-alquil-naltrexona

Country Status (36)

Country Link
US (2) US7645880B2 (es)
EP (1) EP2069362B1 (es)
JP (1) JP5214615B2 (es)
KR (1) KR101434693B1 (es)
CN (2) CN101516892B (es)
AR (1) AR062918A1 (es)
AU (1) AU2007298855B2 (es)
BR (1) BRPI0718440A2 (es)
CA (1) CA2663509C (es)
CL (1) CL2007002711A1 (es)
CO (1) CO6170362A2 (es)
CR (1) CR10660A (es)
DO (1) DOP2011000307A (es)
EA (1) EA015426B1 (es)
ES (1) ES2531093T3 (es)
FR (1) FR2906252B1 (es)
GT (1) GT200900060A (es)
HK (1) HK1135389A1 (es)
HN (1) HN2009000503A (es)
IL (1) IL197402A (es)
JO (1) JO3023B1 (es)
MA (1) MA30793B1 (es)
ME (1) ME00613B (es)
MX (1) MX2009003084A (es)
MY (1) MY148094A (es)
NI (1) NI200900035A (es)
NO (1) NO20091561L (es)
NZ (1) NZ575417A (es)
PE (1) PE20080867A1 (es)
SV (1) SV2009003192A (es)
TN (1) TN2009000080A1 (es)
TW (1) TWI465451B (es)
UA (1) UA96957C2 (es)
UY (1) UY30599A1 (es)
WO (1) WO2008034973A1 (es)
ZA (1) ZA200901846B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008233133B2 (en) 2007-03-29 2014-03-27 Progenics Pharmaceuticals, Inc. Crystal forms of (R) -N-methylnaltrexone bromide and uses thereof
WO2008138383A1 (de) * 2007-05-16 2008-11-20 Cilag Ag Verfahren zur herstellung von n-methylnaltrexonbromid
WO2009009292A2 (en) * 2007-07-11 2009-01-15 Mallinckrodt Inc. Crystalline forms of naltrexone methobromide
EP2019105A1 (en) * 2007-07-19 2009-01-28 Siegfried Ltd. Process for the preparation of quaternary n-alkyl morphine or morphinane alkaloid derivatives
CA2738246C (en) * 2008-09-30 2017-09-05 Mallinckrodt Inc. Processes for the alkylation of secondary amine groups of morphinan derivatives
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
CN102325776A (zh) * 2009-02-23 2012-01-18 马林克罗特公司 (+)-吗啡喃*季盐及其制备方法
JP2012518652A (ja) * 2009-02-23 2012-08-16 マリンクロッド インコーポレイテッド （＋）−６−ヒドロキシ−モルフィナンまたは（＋）−６−アミノ−モルフィナン誘導体
CN102325777B (zh) * 2009-02-23 2015-08-12 马林克罗特公司 (+)-吗啡喃*n-氧化物及其制备方法
KR20120088537A (ko) 2009-04-24 2012-08-08 브럭 유니버시티 모르피난 및 모르피논 화합물의 제조방법
US8829020B2 (en) 2009-07-16 2014-09-09 Mallinckrodt Llc Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
CN101845047B (zh) * 2009-12-31 2011-12-07 南京臣功制药有限公司 一种溴甲基纳曲酮的制备方法
US8580963B2 (en) 2010-11-05 2013-11-12 H. Lundbeck A/S Method for the manufacturing of naltrexone
JO3209B1 (ar) * 2010-11-05 2018-03-08 H Lundbeck As طريقة لتصنيع نالتريكسون
WO2012059103A1 (en) * 2010-11-05 2012-05-10 H. Lundbeck A/S Method for the manufacturing of naltrexone
WO2012138888A1 (en) 2011-04-05 2012-10-11 Alkermes, Inc. Process for the synthesis of quaternary amine compounds
BR112014005421A2 (pt) 2011-09-08 2017-04-04 Mallinckrodt Llc produção de alcaloides sem o isolamento de intermediários
CN103172640A (zh) * 2011-12-22 2013-06-26 天津康鸿医药科技发展有限公司 一种(r)-n-溴甲基纳曲酮的制备方法以及纳曲酮衍生物
AR090916A1 (es) 2012-05-03 2014-12-17 Lundbeck & Co As H Metodo para la fabricacion de naltrexona
CN105985348B (zh) * 2015-02-12 2019-02-01 正大天晴药业集团股份有限公司 一种溴甲基纳曲酮的制备方法
CN106317064B (zh) * 2015-06-30 2018-06-19 北大方正集团有限公司 溴甲纳曲酮的制备方法
KR102201609B1 (ko) * 2019-04-19 2021-01-12 연성정밀화학(주) 날데메딘의 제조방법
CN111777617A (zh) * 2020-07-10 2020-10-16 华润三九医药股份有限公司 一种溴甲纳曲酮的精制方法
EP4225312A1 (en) 2020-10-06 2023-08-16 Scilex Holding Company Oral delayed burst formulation of low-dose naltrexone or naloxone used for treating fibromyalgia and long covid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4176186A (en) * 1978-07-28 1979-11-27 Boehringer Ingelheim Gmbh Quaternary derivatives of noroxymorphone which relieve intestinal immobility
WO2004043964A2 (en) * 2002-11-08 2004-05-27 Mallinckrodt Inc. Process for the preparation of quaternary n-alkyl morphinan alkaloid salts
AR057325A1 (es) * 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos

Also Published As

Publication number Publication date
GT200900060A (es) 2011-01-04
KR20090057031A (ko) 2009-06-03
WO2008034973A1 (fr) 2008-03-27
EA200970307A1 (ru) 2009-12-30
TWI465451B (zh) 2014-12-21
UA96957C2 (ru) 2011-12-26
CO6170362A2 (es) 2010-06-18
MY148094A (en) 2013-02-28
ZA200901846B (en) 2010-07-28
ES2531093T3 (es) 2015-03-10
CN101516892B (zh) 2012-06-20
CL2007002711A1 (es) 2008-04-18
UY30599A1 (es) 2008-05-02
FR2906252A1 (fr) 2008-03-28
CA2663509C (fr) 2014-03-18
EP2069362B1 (fr) 2014-07-09
AR062918A1 (es) 2008-12-17
BRPI0718440A2 (pt) 2013-11-19
KR101434693B1 (ko) 2014-08-27
CR10660A (es) 2009-06-24
MX2009003084A (es) 2009-04-02
NO20091561L (no) 2009-06-16
IL197402A (en) 2012-12-31
FR2906252B1 (fr) 2008-11-28
AU2007298855B2 (en) 2012-09-13
EP2069362A1 (fr) 2009-06-17
AU2007298855A1 (en) 2008-03-27
US20100145051A1 (en) 2010-06-10
US20080214817A1 (en) 2008-09-04
TW200821314A (en) 2008-05-16
PE20080867A1 (es) 2008-08-22
NZ575417A (en) 2011-09-30
IL197402A0 (en) 2009-12-24
JP5214615B2 (ja) 2013-06-19
EA015426B1 (ru) 2011-08-30
JP2010504308A (ja) 2010-02-12
CN102225939A (zh) 2011-10-26
CN101516892A (zh) 2009-08-26
NI200900035A (es) 2010-01-26
HK1135389A1 (en) 2010-06-04
MA30793B1 (fr) 2009-10-01
US8288547B2 (en) 2012-10-16
TN2009000080A1 (en) 2010-08-19
MEP10509A (en) 2011-12-20
DOP2011000307A (es) 2011-10-31
ME00613B (me) 2011-12-20
US7645880B2 (en) 2010-01-12
JO3023B1 (ar) 2016-09-05
HN2009000503A (es) 2011-03-02
CA2663509A1 (fr) 2008-03-27

Similar Documents

Publication Publication Date Title
SV2009003192A (es) Procedimiento de preparacion de halogenuros de n-alquil-naltrexona
ES2555989T3 (es) Procedimiento para la síntesis del ácido 2,5-furanodicarboxílico
BR112012021938A2 (pt) uso de uma mistura de tensoativo para a produção de óleo mineral terciário
BR112012027444A2 (pt) bloco cáustico altamente concentrado para lavagem de louças
MX2009013255A (es) Matriz de solidificacion que incluye una sal de un acido mono-, di- o tri-carboxilico saturado de cadena recta.
EP2374530A8 (en) Foaming composition for high temperature and salinity
DE602007008851D1 (de) Ektionsmittel
MY156416A (en) Alkali-type nonionic surfactant composition
PE20100011A1 (es) Combinacion biocida para utilizacion en aplicaciones agricolas
DE60230676D1 (de) Herstellung von ungefährlichen bromierungsreagenzien
WO2009001777A1 (ja) 二酸化塩素の製造方法、及び該方法に用いる二酸化塩素製造用アルカリ組成物
DK2262751T3 (da) Anvendelse af alkalsulfonsyre som rengøringsmiddel til cement, mørtel og beton
AR071060A1 (es) Proceso para la preparacion de betainas
CL2013000491A1 (es) Proceso para la preparacion de composiciones de cemento, argamasas, hormigon que contienen una mezcla de relleno a base de carbonato de calcio (pre) tratada con un superplastificante; mezcla de relleno; composiciones de cemento; y productos de cemento obtenidos; y sus usos.
BRPI0516335A (pt) composição de limpeza lìquida/gel e processo para a preparação de uma composição de limpeza lìquida/gel
EA201490360A1 (ru) Композиции, содержащие соли аминокислот
RU2011118200A (ru) Способ получения диоксида хлора
WO2008107463A3 (en) Solid detergent composition and process to prepare the same
DOP2009000041A (es) Procedimiento de preparacion de halogenuros de n-alquil-naltrexona
AR073278A1 (es) Procedimiento para sintetizar isoquinolinas sustituidas
EP3593650A3 (en) Preparations capable of increasing the ph of food by releasing molecular hydrogen
WO2007129184A3 (en) An improved process for the preparation of phenytoin sodium
EA201991178A1 (ru) Водная композиция для очистки твердых поверхностей
BRPI0706239A2 (pt) agente fitossanitário para o combate de doenças das plantas causadas por fungos e bactérias, e método para sua obtenção
RU2007107539A (ru) Пенообразователь для конструкционного бетона бг-20х

Legal Events

Date Code Title Description
FG Grant